All Industries

COMCAST OPENS LATEST XFINITY STORE IN EDEN PRAIRIE, MINNESOTA

Comcast Twin Cities

Comcast today announced the opening of its newest Twin Cities area Xfinity Store in Eden Prairie, Minnesota. Located off bustling Commonwealth Drive, the space is thoughtfully designed with the customer experience at the forefront, providing an opportunity to explore and interact directly with the latest Xfinity products and services. The store is located at 8266 Commonwealth Dr, Eden Prairie, MN 55344, and is now open to the public. This opening marks the 15 th Xfinity Store in the Twin Cities metro area. With a modern and open environment that highlights Comcast’s entertainment and technology offerings, the new store encourages customers to work with dedicated store employees and interact with the latest Xfinity products. Products range from internet, video, connected home solutions, Xfinity Mobile, a flexible and affordable wireless plan, and Comcast Business solutions, including new mobile offerings for any size business. The store is equipped to host live demos and provide hands-on account management services. Customers can also conveniently book appointments online ahead of time through Xfinity’s website. “We are happy to welcome Comcast to Eden Prairie as the location for their newest Xfinity store,” said Pat MulQueeny, President of the Eden Prairie Chamber of Commerce. “The Chamber knows how important access to the newest technology is, and with the store’s prime location, it is easier than ever for Eden Prairie customers to access the latest technology and stay connected.” Comcast has also further invested in the Eden Prairie community by donating $5,000 to the Eden Prairie Crime Prevention Fund for their annual youth Safety Camp, where children learn about safety from local police, fire, and recreation departments. “We are thrilled to bring this new state-of-the-art store to Eden Prairie,” said Rachel Johnson, vice president, Sales and Marketing, Comcast Midwest. “Xfinity’s unprecedented coverage is only getting faster, smarter and more reliable, and it is exciting to see more and more communities taking advantage of our unmatched products and services.” The store is open daily from 10:00 a.m. to 8:00 p.m., Monday through Saturday and 11:00 a.m. to 6:00 p.m. on Sunday. About Comcast Corporation Comcast Corporation (Nasdaq: CMCSA) is a global media and technology company. From the connectivity and platforms we provide, to the content and experiences we create, our businesses reach hundreds of millions of customers, viewers, and guests worldwide. We deliver world-class broadband, wireless, and video through Xfinity, Comcast Business, and Sky; produce, distribute, and stream leading entertainment, sports, and news through brands including NBC, Telemundo, Universal, Peacock, and Sky; and bring incredible theme parks and attractions to life through Universal Destinations & Experiences. Visit www.comcastcorporation.com for more information. Contact Details Jill Hornbacher +1 651-425-1695 Jill_Hornbacher@comcast.com Company Website https://midwest.comcast.com

February 08, 2024 08:00 AM Central Standard Time

Image

Roberts & Ryan Inc., America's first Service-Disabled Veteran-Owned (SDVO) broker-dealer, is pleased to welcome Mark DeVito as its Senior Director of Equity Trading.

Roberts & Ryan, Inc.

Mr. DeVito joins Roberts & Ryan as a seasoned business veteran, whose 35-year career has included leadership roles in investment banking, corporate finance, capital market transactions, alternative investments, and corporate boards. Prior to joining Roberts & Ryan, Mr. DeVito was Managing Director of the Global Investment Banking Group at Bank of America Securities, where he developed key client relationships and originated investment banking transactions. Before Bank of America Securities, Mr. DeVito was Managing Partner at JCS Partners LLC. Prior to that, he was Managing Director of Global Energy and Power Investment Banking at Merrill Lynch. Additionally, while at Merrill Lynch, he was the Global Head of their Alternative Investments Group and Managing Director of their Debt Capital Markets Group. Prior to that, he was Senior Vice President of Investment Banking and Capital Markets at Lehman Brothers and Assistant Vice President at Shearson Lehman Hutton. Mr. DeVito served as a member of the Board of Directors of Nextremity Solutions, the Board of Trustees of Rumson Country Day School and the Executive Board of Family and Children’s Services. When asked to share his thoughts on Roberts & Ryan's latest appointment, Chief Executive Officer Ed D'Alessandro remarked, “I am very excited to welcome Mark to our team. His extensive experience and distinguished investment banking career will be a tremendous asset to Roberts & Ryan. Mark is committed to our social mission of supporting Veterans and their families, and his investment banking experience will be instrumental in helping us grow. We are truly fortunate to have someone of Mark’s caliber join our team to help us get to the next level.” Mr. DeVito is a graduate of Fordham University’s Gabelli School of Business, where he received an MBA in Finance, and a graduate of Seton Hall University, where he received a BA in Finance. About Roberts and Ryan, Inc. Roberts & Ryan, Inc. is a Service-Disabled Veteran Owned (SDVO) broker-dealer with execution capabilities in the capital markets, equities, and fixed-income trading. The firm was founded in 1987 by a United States Marine Corps Vietnam combat veteran and Purple Heart recipient. With over $1.8 million in committed donations, Roberts & Ryan is active in donating to charitable foundations that make significant positive impacts in the lives of Veterans and their families, primarily focusing on general wellness, mental health, and career transition. To learn more about Roberts & Ryan, please visit www.roberts-ryan.com. Contact Details Michael C. Del Priore +1 646-859-4061 mdelpriore@roberts-ryan.com Company Website https://www.roberts-ryan.com

February 08, 2024 09:00 AM Eastern Standard Time

Image

Diamond Lake Minerals CEO Brian Esposito Unveils Strategic Vision for Real Estate Tokenization

Diamond Lake Minerals Inc

Diamond Lake Minerals CEO Brian J. Esposito joined Steve Darling from Proactive to discuss the company's presence at a conference in Miami and its distinctive approach to digital assets. Esposito emphasized that Diamond Lake Minerals primarily focuses on Security Token Offerings (STOs) within a regulated environment, setting them apart from unregulated cryptocurrencies. This commitment to regulatory compliance and security is central to the company's approach in the digital asset space. The CEO also stressed the importance of transparency and adherence to regulations within the digital asset sector. Esposito elaborated on the potential of blockchain technology for tokenizing real estate, particularly properties with high leverage or potential risk factors. By using security token offerings, Diamond Lake Minerals aims to bring liquidity and capital to traditionally illiquid assets, enabling fractional ownership and making it accessible to retail investors. Esposito underscored the value of allowing retail investors to own fractional shares in real estate, opening up new opportunities for wealth generation. In response to concerns about the abundance of opportunities in the market, he assured that Diamond Lake Minerals places a premium on rigorous vetting processes to ensure the safety and profitability of business transactions. The CEO expressed a strong commitment to building a diverse portfolio of holdings across various industries, with a focus on maximizing value for shareholders and security token holders. Contact Details Proactive Canada Proactive Canada +1 604-688-8158 action@proactiveinvestors.com

February 08, 2024 08:59 AM Eastern Standard Time

Video

Can the QQQ bull run continue? Play The Tech Trade With This Leveraged ETF

Benzinga

By Faith Ashmore, Benzinga Exchange-traded funds, or ETFs, have long had the reputation of being relatively more stable investment opportunities. These funds aim to mirror the performance of a basket of equities or a specific index, which offers broad market exposure while reducing the risk associated with individual stocks. One of the ETFs that has been on the radar of investors lately is Invesco QQQ Trust (NASDAQ: QQQ). QQQ tracks the performance of the Nasdaq-100 Index, which represents the 100 largest non-financial companies listed on the Nasdaq Stock Market. QQQ is best known for providing investors with exposure to companies at the forefront of innovation across various sectors, including technology, healthcare and communication services. Over the past year, QQQ has gained 45% and led all inflows in late January. Late January marked a 1.4% gain in assets, and assets under management now stand at around $246 billion. QQQ’s recent performance comes on the heels of the Federal Reserve’s announcement in December to keep interest rates at the current level, signaling a potential end to the central bank's cycle of rate hikes and a potential shift towards rate cuts in 2024. This decision reflects the Federal Reserve's response to more positive economic conditions and its efforts to support economic growth and stability. Lower interest rates historically stimulate increased borrowing and investment. While QQQ offers a basic solution to owning stocks in more established growth verticals, some ETFs like the AXS 2X Innovation ETF (NASDAQ: TARK) take a more targeted approach to investing in the companies of tomorrow. How is this accomplished? Quite simply, TARK provides two times daily exposure to the ARK Innovation ETF (NYSE: ARKK), which itself is a more concentrated portfolio of 35 growth equities. TARK gives you daily leveraged exposure to companies that are pioneers in disruptive technologies like next-gen internet, electric vehicles, genomics and fintech. These industries are growing at rapid paces and making big splashes. For example, fintech revenues are projected to grow sixfold and reach $1.5 trillion by 2030. Similarly, worldwide adoption of electric vehicles is fostering a steady annual growth rate within the industry. The global genomics market is expected to reach $83.1 billion by 2028. For investors who have doubted the strength of industries like virtual reality, the numbers don’t lie; the global virtual reality in the gaming market is expected to expand at a CAGR of 31% from 2023 to 2033. The broader gaming industry is even growing in unsuspecting markets; for example, the Middle East is reporting that 60% of the population considers themselves gaming enthusiasts. These industries are hitting home with a lot of younger audiences as well who are more technologically savvy. In 2023, TARK received the Best ETF Launch Award at the Benzinga 2023 Global Fintech Awards and is part of AXS Investments’ family of ETFs focused on a variety of exposures that surround the “Innovation Trade.” While QQQ is capturing the success of the present, ETFs like TARK look to capture the success of the future. In recent years, investors have witnessed an explosion of disruptive technology that has permeated various industries, reshaping the way we live, work and interact. The explosion of disruptive technology in key industries like transportation, health and finance has not only improved efficiency and convenience but has also created new economic opportunities and transformed entire ecosystems. In the coming decades, it seems evident that this trend will continue to accelerate. ETFs like TARK that are capitalizing on disruptive technologies could be poised to grow alongside these industries. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

February 08, 2024 08:50 AM Eastern Standard Time

Longeveron (NASDAQ: LGVN) Making Inroads With Lomecel-B™ – Biotech’s Investigational Alzheimer’s Treatment Shows Positive Trial Results

Benzinga

By Meg Flippin, Benzinga Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotech company aiming to slow the effects of life-threatening and chronic aging-related conditions using cellular therapies, is making inroads with Lomecel-B™, its investigational treatment for hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and aging-related frailty. On October 5th, the Miami-based biotech announced that Lomecel-B™ met its primary safety endpoint and showed a lack of deterioration in cognitive or atrophy signals in approximately 50 patients aged 60 to 85 years old with mild Alzheimer’s disease, marking a major milestone for the company. The successful trial paves the way for more clinical studies of this potentially game-changing treatment. “We believe these results provide important validation of both the safety and therapeutic potential of Lomecel-B™ in the treatment of Alzheimer’s disease and provide a robust foundation for additional clinical trials in this and other indications,” Wa’el Hashad, CEO of Longeveron, said announcing the trial results. In late December, the company released additional new clinical and biomarker results from the trial that reinforced the earlier top-line findings. Additional analysis of cognitive function and daily living data showed favorable results with Lomecel-B™ over placebo. The drug was shown to slow and in some cases improve certain measurements of cognitive function (MoCA, MMSE). Funding Development In addition to reporting promising results for Lomecel-B™, in October 2023, Longeveron secured $4 million in gross proceeds before expenses from a round of equity financing. In late December, Longeveron closed a previously announced registered direct offering of 1.35 million shares priced at $1.62 per share, raising an additional $2.36 million in gross proceeds. Longeveron plans to use the net proceeds to fund the ongoing clinical and regulatory development of Lomecel-B™ and for capital expenditures, working capital, and general corporate purposes. The company reported that as of the end of the third quarter, it has enough existing cash and short-term investments to cover expenses and capital requirements into the first quarter of 2024. Investor Aspirations And Stock Trend Some investors are hopeful that Lomecel-B™ could possibly play a role in the future in treating Alzheimer’s disease, which affects about 6.7 million people 65 and older in the U.S. In 2023 alone, Alzheimer’s and other dementias will cost the U.S. $345 billion, according to the Alzheimer’s Association. By 2050, total payments for healthcare, long-term care and hospice for those with dementia are projected to reach nearly $1 trillion. Lomecel-B™ appears to target inflammation, and it is believed that inflammation plays a role in the onset and progression of Alzheimer’s disease. Researchers made this discovery after several studies showed that people who took anti-inflammatory drugs like Enbrel and Humira were as much as 50% less likely to develop Alzheimer's disease later in life. These discoveries have in part helped to spur a new class of investigational drugs that aim to treat and cure Alzheimer’s disease by targeting inflammation. Lomecel-B™ is made from medical signaling cells (MSCs) derived from the bone marrow of healthy adult donors. It is believed that these cells travel to sites of damage or inflammation in the body and promote cellular regeneration and repair. More Potential Catalysts On The Horizon? Lomecel-B™ as a potential treatment for Alzheimer’s isn’t the only possible catalyst on the horizon for Longeveron, and investors may want to watch for more to come. The therapeutic treatment is also in stage 2 trials to treat Hypoplastic Left Heart Syndrome (HLHS) and Aging-related frailty. HLHS is a rare pediatric congenital heart defect that affects about 1,000 babies in the U.S. annually. The left side of the heart fails to develop in patients with HLHS – leading to short-term mortality, delayed development and long-term organ failure. Lomecel-B™ is administered directly into the cardiac tissue of the right ventricle for HLHS patients. The goal is to improve cardiac function through the regenerative, pro-vascular and anti-inflammatory effects of MSCs. Results from a phase 1 ELPIS 1 trial showed 100% survival in Lomecel-B™-treated children at up to five years of age. Historically, children with HLHS have about 20% mortality by five years. The results were encouraging enough for Lomecel-B™ to be given the Rare Pediatric Disease Designation (RPD), Orphan Drug Designation (ODD) and Fast Track Designation from the FDA. A phase 2 trial in HLHS of 38 patients is currently underway. In August, the trial surpassed the 50% enrollment threshold. The company is also in a phase 2 trial of Lomecel-B™ to treat aging-related frailty, which is characterized by mobility disability, weakness, fatigue, weight loss, slowness and low activity. Its current phase 2 trial will include 45 patients in Japan, where nearly a third of the population is over 65. “With our Phase 2 ELPIS II trial in HLHS moving toward anticipated completion in 2024, and our Phase 2 program in Aging-related frailty progressing in Japan as well, we look forward to meaningful milestones in the near term and to fully realizing the therapeutic potential of Lomecel-B™,” said Hashad. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

February 08, 2024 08:45 AM Eastern Standard Time

CIA WINE & BEVERAGE SUMMIT RETURNS TO NAPA

Culinary Institute of America

For the first time in four years, the Culinary Institute of America’s Wine & Beverage Summit —a three-day gathering of the beverage industry’s best and brightest—returns to the CIA at Copia May 5-7. Featuring everything from immersive tastings to in-depth dialogue on the state of wine education, innovative career paths, and increasing both business savvy and financial fluency, the conference will welcome recognized wine experts and rising stars alike. It is ideal for junior and mid-level industry professionals looking to grow their knowledge and advance their careers. “We are thrilled to bring back this incredible event with a focus on professional development,” said Maryam Ahmed, consulting program director. “Attendees can expect a truly enriching experience. Unlike larger conferences where one-way presentations are the focus, this summit was deliberately crafted to be a smaller, more intimate gathering so attendees can interact directly with the presenters and each other during breakout sessions and receptions.” Among the esteemed beverage experts and presenters are: Emily Wines, certified master sommelier, and vice president of wine experience at Coopers Hawk Winery and Restaurant; Erik Segelbaum, founder and chief vinnovation officer at SOMLYAY, LLC; TJ Douglas, CEO and founder of the Drink Progressively Group; and Andrea Robinson, master sommelier, author, and consultant to Delta Airlines and Norwegian Cruise Line. The conference also serves as one of the residency sites for CIA Wine and Beverage Management master’s degree students, who will attend as part of their program. For more information or to view the full program schedule, visit ciabevpro.com. About The Culinary Institute of America Founded in 1946, The Culinary Institute of America is the world’s premier culinary college. Dedicated to developing leaders in foodservice and hospitality, the independent, not-for-profit CIA offers associate, bachelor’s, and master's degrees with majors in culinary arts, baking & pastry arts, food business management, hospitality management, culinary science, and applied food studies. The college also offers executive education, certificate programs, and courses for professionals and enthusiasts. Its conferences, leadership initiatives, and consulting services have made the CIA the think tank of the food industry and its worldwide network of more than 50,000 alumni includes innovators in every area of the food world. The CIA has locations in New York, California, Texas, and Singapore. For more information, visit www.ciachef.edu. Contact Details Amanda Secor +1 845-451-1457 amanda.secor@culinary.edu

February 08, 2024 08:45 AM Eastern Standard Time

Image

Each Year, More Than 200 Workers Die From Silicosis; Laser Photonics’ Innovative Technology Is Helping Make This A Thing Of The Past

Benzinga

By Faith Ashmore, Benzinga While manufacturing is essential to our 21st-century world, it can present significant health risks to workers. As a responsible society, it is our duty to continually evaluate the methods we use to increase the safety and health of workers around the globe. One example of a health hazard of manufacturing is silicosis, a progressive and irreversible lung disease caused by the inhalation of crystalline silica dust. Historically, sandblasting has been the primary method for industrial cleaning in industries around the world. This process involves using high-pressure air to propel abrasive particles onto the surface of a material to remove coatings, corrosion or other contaminants. The projection of a high-velocity stream of abrasive particles often includes silica sand. Silica sand contains crystalline silica, the known cause of silicosis. Consequently, sandblasting has faced increasing criticism due to the health and safety issues it poses. When workers are exposed to airborne crystalline silica particles during sandblasting operations, they can inhale the dust, and it can settle deep into the lungs. Over time, this can lead to the development of silicosis. The disease can manifest in different forms, including acute, accelerated and chronic silicosis. Each year in the U.S., more than 200 workers die from this illness while hundreds more become disabled. Many workers with silicosis are only in their thirties and some are as young as 22 years old. To mitigate the risks associated with sandblasting in manufacturing, it is important to implement proper controls and protective measures like comprehensive exhaust ventilation. However, one company has been working to disrupt the blasting industry, which is set to grow to $12 billion by 2025 according to Reliable Research Reports. Through laser cleaning, industrial professionals eliminate waste disposal costs and problems while avoiding the risk of silicosis sandblasting can pose. Laser Photonics Corporation (NASDAQ: LASE) (“LPC”), a leading global industrial pioneer of laser systems, is known for its line of cutting-edge laser cleaning products. With its CDHR and FDA-certified CleanTech systems, LPC provides industry professionals with a laser-blasting solution for corrosion control, coating removal, pre-weld preparation, post-weld treatment, laser cleaning, surface conditioning and more. Laser Photonics’ CleanTech lasers are known for their advanced technology and safety features that contribute to the company’s reputation as a safer and more accurate option compared to other blasting methods. The CleanTech laser systems operate by concentrating a high-powered laser onto the targeted area for cleaning purposes, and LPC reports that this technology effectively eliminates substances such as rust, corrosion, residue and paint from different materials without causing any harm to the surface beneath. By harnessing the energy released during the laser cleaning process, contaminants are efficiently and precisely removed from substrates – protecting operators from the potential hazards of using harmful chemicals and substances. LPC has been continuing to expand its existing product line to better serve customers in various industries such as energy, nuclear, defense, maritime, shipbuilding and automotive. While manufacturing is essential to key industries, the health of workers is paramount to the sustained growth of manufacturing. Laser Photonics’s innovative technology puts workers first while elevating industry standards. Silicosis is a largely preventable disease, and LPC’s forward-thinking processes play a pivotal role in enhancing operator and environmental safety. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

February 08, 2024 08:35 AM Eastern Standard Time

Cannara Biotech Q1 Results: Revenue, Net Income And Market Share Up, Quarter Also Marks Company’s First Export Sale

Benzinga

By Meg Flippin, Benzinga With the demand for high-quality, affordably priced cannabis growing in Canada, Cannara Biotech Inc.'s (OTCMKTS: LOVFF) investments seem to be paying off. The vertically integrated producer of premium-grade cannabis and derivative product offerings has used investment dollars to produce quality cannabis products and increase the number of growing zones. That has resulted in Montreal-based Cannara Biotech reporting record-setting revenue for its first quarter and forecast even more growth to come in 2024. For the first quarter ending November 30, 2023, Cannara posted net revenue of $19.5 million, an 89% year-over-year increase and net income of $2.1 million, up significantly from $2,954 in the year-ago first quarter. Meanwhile, gross profit before fair value adjustments of $7.9 million was up 98% from the year-ago first quarter and earnings before interest, taxes, depreciation and amortization (EBITDA) of $5.2 million marked a 206% increase. “Our first quarter results are continued solid proof of Cannara's strong financial health and strategic approach to business operations,” Nicholas Sosiak, CFO of Cannara said when reporting quarterly results. ”We have seen impressive sales increases and a steady rise in adjusted EBITDA, net income and cash flow from operations, which sets a strong base for the rest of the year.” Quality Cannabis At An Affordable Price Since launching in 2017, Cannara Biotech has been focused on growing quality cannabis products and bringing them to the masses at an affordable price. The company operates two huge facilities spanning over 1,650,000 square feet in Quebec, where it churns out quality cannabis products en masse using its access to low-priced utilities in the province and lean operational structure to keep costs down. It then passes on those savings to its legions of customers. During the first quarter, the company produced from nine growing zones out of its Valleyfield Facility with a 10th growing zone added in January. All told, the company has increased its total production to about 33,500 kg of cannabis per year. That should be welcome news to its investors given sales of cannabis products in Canada are projected to grow at a CAGR of 13.4% between 2021 and 2030. Underscoring that demand, Cannara said it sold 1.34 million units across its three flagship brands during the first quarter, up 99% from the 675,000 units sold in the same period a year ago. Quarter-over-quarter units sold were up 11%. The variety of its product line is also increasing, which could drive sales further in 2024. During the quarter it increased its total national product portfolio of cannabis products by 60% to 155 SKUs from 97. It is innovating in new categories including infused pre-rolls, milled flower and budget-friendly vapes. Market Share Gains Along with an increase in sales during the quarter were market share gains, a key metric given it’s difficult to stand out in the market thanks to climates that make it hard to grow the product, regulatory hurdles and high start-up costs. In Quebec, Canada’s largest market for cannabis, Cannara is the fourth-largest licensed producer, controlling about 8.7% of the market as of the first quarter. In Ontario, it ranks as the ninth top producer and in Alberta, its market share has increased to 2.3% from 1.2% share in the year-earlier first quarter. In British Columbia, it's making inroads, with market share of just under 1%. The company is still at the beginning of its growth, with only 35% of its production capacity activated, and operates in only five main markets in Canada, resulting in many strategies in Cannara’s toolkit to potentially increase its revenues and market share quarter over quarter. Another milestone for Cannara during the first quarter: it completed its first intentional export sale of cannabis product to Israel. Not only does that showcase its ability to be an exporter, it highlights an additional potential revenue stream for the company. A Bright Future Ahead? Looking out to the remainder of 2024, the company plans to increase production capabilities and sales incentives, roll out new products including new formats, release new strains, increase market penetration and continue to post positive Adjusted EBITDA. It’s confident all of that should position it for solid results this year and beyond. "The first quarter of 2024 has been another significant period for Cannara, with record breaking net revenues of $19.5 million, an 89% increase from the comparative quarter in 2023, and an incredible net income surge,” Zohar Krivorot, President and Chief Executive Officer, said of the first quarter results. “As we build on this momentum in 2024, our roadmap is clear, continued execution with excellence, cost efficiencies and product innovation. This strategic expansion is not just about quantity, it is about deepening our market penetration by enriching our customers’ experience with high-quality products that stand out in the market. With a keen eye on evolving market trends and consumer preferences, we are committed to growing our market presence and product portfolio in a purposeful manner." Featured photo courtesy of Cannara Biotech. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

February 08, 2024 08:30 AM Eastern Standard Time

Image

Revolutionizing Cricket Viewing: myco Secures digital streaming rights for HBL PSL Season 9 & 10

PlatoData

Highlights: · myco Secures PSL Streaming Rights: myco, a global blockchain-based video streaming platform, has obtained digital streaming rights for the HBL PSL Seasons 9 & 10, aiming to transform digital sports streaming. · "Watch & Earn" Model: Viewers can watch HBL PSL matches in HD for free on myco and earn from the advertising revenue generated, thanks to the platform's innovative "Watch & Earn" model, which rewards viewers based on their watch time. · Easy Earnings Withdrawal: Through integration with Simpaisa, myco's payment partner, users can conveniently withdraw their earnings directly to over 35 bank accounts and all major digital wallets in Pakistan, making the rewarding experience seamless. · Global Impact and Local Presence: myco's success, highlighted during the ICC World Cup 2023, has established it as a preferred platform for cricket streaming globally and in Pakistan. With partnerships across various sports and a content library exceeding 500,000 items, myco serves a global audience while maintaining a strong local commitment. · Dedication to empowering viewers globally: myco is focused on leveraging its global success to enrich the local content economy, bringing premium sporting events and entertainment to viewers. In a groundbreaking move, myco, the global blockchain-based video streaming platform, has secured the coveted digital streaming rights for HBL PSL Season 9 & 10. This milestone not only reshapes the landscape of digital sports streaming but promises an unparalleled cricket viewing experience for fans in Pakistan. Empowering viewers Cricket enthusiasts can now enjoy the thrilling HBL PSL matches in HD for free on myco. The platform's unique "Watch & Earn" model elevates the viewer experience by allowing them not only to enjoy the game but also empowers viewers to earn based on their watch time. Engaged viewers become stakeholders in the advertising revenues generated by the platform, delivering an interactive and rewarding experience to sports viewing. Seamless Integration with Simpaisa for Reward Withdrawals The integration with myco’s payment partner, Simpaisa, enhances the unique "Watch & Earn" model where users can easily withdraw their earnings directly into 35+ bank accounts and all major digital wallets in Pakistan, adding a seamless and convenient aspect to the rewarding experience. myco's Impact on Global Cricket Streaming The success trajectory of myco gained momentum during the ICC World Cup 2023, where it emerged as the preferred choice for cricket enthusiasts. Trending at the top positions on both app stores and play stores, myco distributed over 20 million PKR worth of advertising revenue to more than 250,000 highly engaged viewers. The platform continues with its streaming of various cricket leagues in Pakistan & globally, including ILT20, SAT20, and SPL. Myco boasts a rich history of collaborations, having partnered with PCB, English Premier League, and the Emirates Cricket Board, as well as major squash, tennis, and racing festivals worldwide. A Global Platform with a Local Heart With a global presence spanning 204 countries and a user base exceeding 6.5 million registered users, myco offers an extensive library comprising over 500,000 content items, ranging from documentaries and films to a diverse array of creator and influencer partnerships, alongside live sports. Somair Rizvi, Co-Founder & COO myco, expressed his enthusiasm, stating, "We are committed to bringing premium sporting events and content libraries to our Pakistani viewers. This move strengthens our dedication to providing top-notch quality entertainment while empowering our viewers to have a sustainable stake within the content economy both from a financial and creative standpoint.” About PSL 9: The 2024 Pakistan Super League (PSL 9) will span 31 days, starting on February 17 and concluding on March 18, with a total of 34 matches scheduled across four venues: Karachi (11 matches), Lahore and Rawalpindi (9 matches each), and Multan (5 matches). While specific global viewership estimates for PSL 2024 are not provided, the league's popularity is evident from past performance, with significant increases in sponsorships and broadcasting rights indicating a wide audience reach. For instance, previous seasons have seen a substantial surge in viewership, with some platforms reporting over 200 million views in just the first 12 days of the season, highlighting the league's broad appeal and growing fan base in Pakistan and Globally. www.myco.io Download the app from your favorite App store About myco myco is a web3 video streaming platform where SVOD and AVOD capabilities have been vertically integrated in a decentralized environment. The myco platform empowers viewers and creators in a fully decentralized video eco-system with live monetization, crowdfunding, gating NFTs and fractional ownership of content. The myco platform has over 6 million registered users from across the globe with major footprint in MENA, North America and Soth Asia, 1,500 leading content creator channels, and more than 500,000 user generated videos, as well as a collection of 50 myco original productions and 1,000 hours of premium exclusive content. Recently myco disrupted the sports streaming space by become the first to offer exclusive live sports in a watch&earn model with participation from top global brands as advertising partners. Contact Details Tariq Jaser, Head of Marketing tariq@myco.io

February 08, 2024 08:28 AM Eastern Standard Time

Image

1 ... 435 436 437 438 439 ... 3764